HEADER TRANSFERASE 17-OCT-08 2W1I TITLE STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 835-1132; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HOMO SAPIENS; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS CHROMOSOMAL REARRANGEMENT, NUCLEOTIDE-BINDING, TYROSINE-PROTEIN KEYWDS 2 KINASE, PROTO-ONCOGENE, PHOSPHOPROTEIN, DISEASE MUTATION, SH2 KEYWDS 3 DOMAIN, TRANSFERASE, ATP-BINDING, POLYMORPHISM, KINASE, CANCER, KEYWDS 4 AURORA, MEMBRANE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR S.HOWARD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR,D.M.CROSS,J.CURRY, AUTHOR 2 L.A.DEVINE,T.R.EARLY,L.FAZAL,A.L.GILL,M.HEATHCOTE,S.MAMAN, AUTHOR 3 J.E.MATTHEWS,R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN,M.O'REILLY, AUTHOR 4 D.C.REES,M.REULE,D.TISI,G.WILLIAMS,M.VINKOVIC,P.G.WYATT REVDAT 2 23-OCT-24 2W1I 1 LINK REVDAT 1 27-JAN-09 2W1I 0 JRNL AUTH S.HOWARD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR,D.M.CROSS, JRNL AUTH 2 J.CURRY,L.A.DEVINE,T.R.EARLY,L.FAZAL,A.L.GILL,M.HEATHCOTE, JRNL AUTH 3 S.MAMAN,J.E.MATTHEWS,R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN, JRNL AUTH 4 M.O'REILLY,D.C.REES,M.REULE,D.TISI,G.WILLIAMS,M.VINKOVIC, JRNL AUTH 5 P.G.WYATT JRNL TITL FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA (AT9283), JRNL TITL 2 A MULTITARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE JRNL TITL 3 ACTIVITY. JRNL REF J.MED.CHEM. V. 52 379 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19143567 JRNL DOI 10.1021/JM800984V REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019F REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 18561 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 992 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1366 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE SET COUNT : 48 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4748 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 131 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.47000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.29000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.403 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.314 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.815 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.863 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4882 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3448 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6579 ; 1.448 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8377 ; 0.906 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 568 ; 6.774 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 258 ;40.637 ;24.233 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 929 ;19.006 ;15.113 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;16.323 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 684 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5330 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 990 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1161 ; 0.216 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3638 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2365 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2692 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 65 ; 0.148 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.154 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 77 ; 0.182 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.182 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2848 ; 0.058 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4612 ; 0.088 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2034 ; 0.085 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1964 ; 0.113 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2W1I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1290037846. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18561 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 29.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 2.180 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.37850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.56450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.37850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 46.56450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 807 REMARK 465 SER A 808 REMARK 465 TYR A 809 REMARK 465 TYR A 810 REMARK 465 HIS A 811 REMARK 465 HIS A 812 REMARK 465 HIS A 813 REMARK 465 HIS A 814 REMARK 465 HIS A 815 REMARK 465 HIS A 816 REMARK 465 ASP A 817 REMARK 465 TYR A 818 REMARK 465 ASP A 819 REMARK 465 ILE A 820 REMARK 465 PRO A 821 REMARK 465 THR A 822 REMARK 465 THR A 823 REMARK 465 GLU A 824 REMARK 465 ASN A 825 REMARK 465 LEU A 826 REMARK 465 TYR A 827 REMARK 465 PHE A 828 REMARK 465 GLN A 829 REMARK 465 GLY A 830 REMARK 465 ALA A 831 REMARK 465 MET A 832 REMARK 465 GLY A 833 REMARK 465 SER A 834 REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ARG A 923 REMARK 465 MET B 807 REMARK 465 SER B 808 REMARK 465 TYR B 809 REMARK 465 TYR B 810 REMARK 465 HIS B 811 REMARK 465 HIS B 812 REMARK 465 HIS B 813 REMARK 465 HIS B 814 REMARK 465 HIS B 815 REMARK 465 HIS B 816 REMARK 465 ASP B 817 REMARK 465 TYR B 818 REMARK 465 ASP B 819 REMARK 465 ILE B 820 REMARK 465 PRO B 821 REMARK 465 THR B 822 REMARK 465 THR B 823 REMARK 465 GLU B 824 REMARK 465 ASN B 825 REMARK 465 LEU B 826 REMARK 465 TYR B 827 REMARK 465 PHE B 828 REMARK 465 GLN B 829 REMARK 465 GLY B 830 REMARK 465 ALA B 831 REMARK 465 MET B 832 REMARK 465 GLY B 833 REMARK 465 SER B 834 REMARK 465 ALA B 835 REMARK 465 PHE B 836 REMARK 465 GLU B 837 REMARK 465 ASP B 838 REMARK 465 ARG B 839 REMARK 465 ASP B 840 REMARK 465 PRO B 841 REMARK 465 THR B 842 REMARK 465 ALA B 920 REMARK 465 GLY B 921 REMARK 465 ARG B 922 REMARK 465 ARG B 923 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2034 O HOH A 2035 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 846 -48.77 -27.92 REMARK 500 PHE A 860 -15.47 123.24 REMARK 500 GLN A 872 -5.36 56.61 REMARK 500 ASN A 874 18.12 80.81 REMARK 500 THR A 888 -178.40 -54.42 REMARK 500 LYS A 945 129.84 -13.19 REMARK 500 GLU A 946 -27.38 61.92 REMARK 500 ASP A 976 43.20 -161.45 REMARK 500 GLU A 987 -47.98 -10.52 REMARK 500 ASP A 994 80.95 51.96 REMARK 500 GLN A1072 -38.93 -38.64 REMARK 500 PRO A1095 152.67 -46.72 REMARK 500 LEU B 852 -54.42 -130.69 REMARK 500 ASN B 859 -92.77 49.11 REMARK 500 GLN B 885 -78.16 -69.94 REMARK 500 HIS B 886 67.32 -111.95 REMARK 500 THR B 888 -155.44 -111.98 REMARK 500 LYS B 945 122.79 -24.83 REMARK 500 GLU B 946 -12.65 79.69 REMARK 500 ASP B 976 45.20 -163.62 REMARK 500 ASP B 994 77.87 53.30 REMARK 500 GLU B1012 18.91 108.88 REMARK 500 ILE B1051 39.67 39.62 REMARK 500 SER B1056 152.58 -47.53 REMARK 500 GLN B1070 -27.00 -140.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L0I A2133 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2B7A RELATED DB: PDB REMARK 900 THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY APOTENT AND REMARK 900 SPECIFIC PAN-JANUS KINASE INHIBITOR REMARK 900 RELATED ID: 2W1G RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1F RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1D RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1H RELATED DB: PDB REMARK 900 FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4- YL UREA (AT9283), A REMARK 900 MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY REMARK 900 RELATED ID: 2W1E RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1C RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR DBREF 2W1I A 807 834 PDB 2W1I 2W1I 807 834 DBREF 2W1I A 835 1132 UNP O60674 JAK2_HUMAN 835 1132 DBREF 2W1I B 807 834 PDB 2W1I 2W1I 807 834 DBREF 2W1I B 835 1132 UNP O60674 JAK2_HUMAN 835 1132 SEQRES 1 A 326 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 326 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 326 GLY SER ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU SEQRES 4 A 326 GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY SEQRES 5 A 326 ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU SEQRES 6 A 326 GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU SEQRES 7 A 326 GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG SEQRES 8 A 326 GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE SEQRES 9 A 326 VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG SEQRES 10 A 326 ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER SEQRES 11 A 326 LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP SEQRES 12 A 326 HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS SEQRES 13 A 326 GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG SEQRES 14 A 326 ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN SEQRES 15 A 326 ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU SEQRES 16 A 326 PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY SEQRES 17 A 326 GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR SEQRES 18 A 326 GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE SEQRES 19 A 326 GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SEQRES 20 A 326 SER LYS SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY SEQRES 21 A 326 ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE SEQRES 22 A 326 GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP SEQRES 23 A 326 GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS SEQRES 24 A 326 TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP SEQRES 25 A 326 LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP GLN MET ALA SEQRES 26 A 326 GLY SEQRES 1 B 326 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 B 326 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 B 326 GLY SER ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU SEQRES 4 B 326 GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY SEQRES 5 B 326 ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU SEQRES 6 B 326 GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU SEQRES 7 B 326 GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG SEQRES 8 B 326 GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE SEQRES 9 B 326 VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG SEQRES 10 B 326 ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER SEQRES 11 B 326 LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP SEQRES 12 B 326 HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS SEQRES 13 B 326 GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG SEQRES 14 B 326 ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN SEQRES 15 B 326 ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU SEQRES 16 B 326 PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY SEQRES 17 B 326 GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR SEQRES 18 B 326 GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE SEQRES 19 B 326 GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SEQRES 20 B 326 SER LYS SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY SEQRES 21 B 326 ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE SEQRES 22 B 326 GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP SEQRES 23 B 326 GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS SEQRES 24 B 326 TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP SEQRES 25 B 326 LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP GLN MET ALA SEQRES 26 B 326 GLY MODRES 2W1I PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 2W1I PTR A 1008 TYR O-PHOSPHOTYROSINE MODRES 2W1I PTR B 1007 TYR O-PHOSPHOTYROSINE MODRES 2W1I PTR B 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET L0I A2133 52 HETNAM PTR O-PHOSPHOTYROSINE HETNAM L0I 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3- HETNAM 2 L0I YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 L0I C19 H24 N7 O2 1+ FORMUL 4 HOH *131(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 GLU A 889 SER A 904 1 16 HELIX 3 3 SER A 936 HIS A 944 1 9 HELIX 4 4 ASP A 949 LYS A 970 1 22 HELIX 5 5 ALA A 978 ARG A 980 5 3 HELIX 6 6 PRO A 1017 TYR A 1021 5 5 HELIX 7 7 ALA A 1022 SER A 1029 1 8 HELIX 8 8 SER A 1032 THR A 1049 1 18 HELIX 9 9 GLU A 1052 LYS A 1055 5 4 HELIX 10 10 SER A 1056 GLY A 1066 1 11 HELIX 11 11 GLY A 1071 ASN A 1084 1 14 HELIX 12 12 PRO A 1095 TRP A 1106 1 12 HELIX 13 13 ASN A 1109 ARG A 1113 5 5 HELIX 14 14 SER A 1115 GLY A 1132 1 18 HELIX 15 15 GLU B 845 ARG B 847 5 3 HELIX 16 16 GLU B 889 LEU B 905 1 17 HELIX 17 17 SER B 936 HIS B 944 1 9 HELIX 18 18 ASP B 949 LYS B 970 1 22 HELIX 19 19 ALA B 978 ARG B 980 5 3 HELIX 20 20 PRO B 1017 TYR B 1021 5 5 HELIX 21 21 ALA B 1022 SER B 1029 1 8 HELIX 22 22 SER B 1032 THR B 1049 1 18 HELIX 23 23 GLU B 1052 LYS B 1055 5 4 HELIX 24 24 SER B 1056 GLY B 1066 1 11 HELIX 25 25 GLY B 1071 ASN B 1084 1 14 HELIX 26 26 PRO B 1095 TRP B 1106 1 12 HELIX 27 27 ASN B 1109 ARG B 1113 5 5 HELIX 28 28 SER B 1115 GLY B 1132 1 18 SHEET 1 AA 5 LEU A 849 GLY A 856 0 SHEET 2 AA 5 GLY A 861 TYR A 868 -1 O VAL A 863 N LEU A 855 SHEET 3 AA 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 AA 5 LYS A 926 MET A 929 -1 O LEU A 927 N LYS A 882 SHEET 5 AA 5 TYR A 913 CYS A 917 -1 N LYS A 914 O ILE A 928 SHEET 1 AB 2 TYR A 972 ILE A 973 0 SHEET 2 AB 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AC 2 ILE A 982 ASN A 986 0 SHEET 2 AC 2 ARG A 989 ILE A 992 -1 O ARG A 989 N GLU A 985 SHEET 1 AD 2 PTR A1008 LYS A1009 0 SHEET 2 AD 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 BA 5 LEU B 849 GLY B 856 0 SHEET 2 BA 5 GLY B 861 TYR B 868 -1 O VAL B 863 N LEU B 855 SHEET 3 BA 5 GLU B 877 LEU B 884 -1 O GLU B 877 N TYR B 868 SHEET 4 BA 5 LYS B 926 GLU B 930 -1 O LEU B 927 N LYS B 882 SHEET 5 BA 5 TYR B 913 CYS B 917 -1 N LYS B 914 O ILE B 928 SHEET 1 BB 2 TYR B 972 ILE B 973 0 SHEET 2 BB 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 BC 2 ILE B 982 ASN B 986 0 SHEET 2 BC 2 ARG B 989 ILE B 992 -1 O ARG B 989 N GLU B 985 SHEET 1 BD 2 PTR B1008 LYS B1009 0 SHEET 2 BD 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.32 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 LINK C GLU B1006 N PTR B1007 1555 1555 1.34 LINK C PTR B1007 N PTR B1008 1555 1555 1.33 LINK C PTR B1008 N LYS B1009 1555 1555 1.34 CISPEP 1 LYS A 1011 GLU A 1012 0 7.64 CISPEP 2 LYS B 1011 GLU B 1012 0 -17.44 SITE 1 AC1 10 LEU A 855 GLY A 856 VAL A 863 ALA A 880 SITE 2 AC1 10 GLU A 930 TYR A 931 LEU A 932 PRO A 933 SITE 3 AC1 10 GLY A 935 LEU A 983 CRYST1 102.757 93.129 123.269 90.00 146.58 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009732 0.000000 0.014748 0.00000 SCALE2 0.000000 0.010738 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014729 0.00000